| BSE: 532488 | Sector: Health care |
| NSE: DIVISLAB | ISIN Code: INE361B01024 |
| BSE 00:00 | 16 Jan | 1520.75 |
-2.20 (-0.14%) |
OPEN
1522.95 |
HIGH
1525.55 |
LOW
1515.00 |
| NSE 00:00 | 16 Jan | 1519.80 |
-2.40 (-0.16%) |
OPEN
1526.05 |
HIGH
1526.05 |
LOW
1512.65 |
| OPEN | 1522.95 |
| PREVIOUS CLOSE | 1522.95 |
| VOLUME | 13883 |
| 52-Week high | 1577.00 |
| 52-Week low | 978.50 |
| P/E | 35.11 |
| Mkt Cap.(Rs cr) | 40,368 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
12.47 pm | 26 Dec 2018 | Business Standard
The year 2018 witnessed three pharma stocks scaling their lifetime high. They are Divi's Laboratories, Biocon and Piramal Enterprises (PEL).
12.45 pm | 16 Nov 2018 | Business Standard
The stock hit a new high of Rs 1,574, up 3% on the BSE today.
6.07 pm | 29 Oct 2018 | Business Standard
BS ReporterHyderabad, 29 October: Active pharmaceutical ingredients(APIs) and drug intermediates maker Divis Laboratories Limited is creating additio...
9.41 am | 29 Oct 2018 | Business Standard
The stock surged 14% to Rs 1,433 on the BSE in early morning trade on Monday, after reported a healthy 92% Y-o-Y jumped in net profit at Rs 3.98 billi...
8.12 am | 27 Sep 2018 | Business Standard
Analysts have upgraded estimates on supply disruption, weak rupee
10.20 am | 23 Aug 2018 | Business Standard
Nifty Pharma index hit a 52-week high of 10,142, rising 2%, in early morning deal, surpassing its previous high of 10,063 recorded on November 3, 2017...
2.08 pm | 2 Aug 2018 | Business Standard
Divi's Lab, Aurobindo Pharma, Lupin, Dr Reddy's Lab, Sun Pharma, Glenmark Pharma and Cipla from the Nifty pharma index were up in the range of 1% to 3...
Copyrights © 2019 Business Standard Private Ltd. All rights reserved.
